Cronos Group Inc. (CRON) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$2.62
Price Target
$2.30
Target Range
$2.30 — $2.30
Analyst Rating
Hold
Forward P/E34.9x
Trailing P/E—
Forward PEG—
Implied Growth—
Median Target$2.30
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$2
-12.2%
Consensus
$2
-12.2%
Bull Case
$2
-12.2%
CRON Price Target Analysis
Updated May 7, 2026As of May 7, 2026, Cronos Group Inc. (CRON) has a Wall Street consensus price target of $2.30, based on estimates from 15 covering analysts. With the stock currently trading at $2.62, this represents a potential downside of -12.2%. The company has a market capitalization of $1000M.
Analyst price targets range from a low of $2.30 to a high of $2.30, representing a 0% spread in expectations. The median target of $2.30 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 3 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, CRON trades at a forward P/E of 34.9x.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+164.1%
Avg Forward P/E14.7x
Peers with Coverage8 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CGCCanopy Growth Corporation | $124M | $1.15 | $14.47 | +1158.3% | Hold | — | 26 |
 TLRYTilray Brands, Inc. | $671M | $5.76 | $10.00 | +73.6% | Hold | — | 20 |
 ACBAurora Cannabis Inc. | $201M | $3.54 | $5.92 | +67.2% | Hold | — | 14 |
 IIPRInnovative Industrial Properties, Inc. | $1.6B | $57.69 | $44.00 | -23.7% | Hold | 13.4x | 11 |
 SMGThe Scotts Miracle-Gro Company | $3.6B | $62.85 | $72.00 | +14.6% | Buy | 14.3x | 17 |
 HYFMHydrofarm Holdings Group, Inc. | $5M | $1.14 | — | — | — | — | — |
 MAPSWM Technology, Inc. | $18M | $0.37 | — | — | — | — | — |
 MOAltria Group, Inc. | $117.3B | $70.17 | $68.50 | -2.4% | Buy | 12.4x | 26 |
 PMPhilip Morris International Inc. | $265.8B | $170.53 | $187.60 | +10.0% | Buy | 20.3x | 25 |
 STZConstellation Brands, Inc. | $26.4B | $152.29 | $175.70 | +15.4% | Buy | 12.9x | 46 |
Upside Potential Comparison
CGCTLRYACBSTZSMGPMMOIIPRSee CRON's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRON Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRON vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRON — Frequently Asked Questions
Quick answers to the most common questions about buying CRON stock.
What is the CRON stock price target for 2026?
CRON's consensus price target is $2.3, -12.2% below the current price of $2.62. The 15 analysts tracking CRON see downside risk at present valuations.
Is CRON a buy, sell, or hold?
CRON has a consensus rating of "Hold" based on 15 Wall Street analysts. The rating breakdown is mixed, with 9 Hold ratings making up the largest segment. The consensus 12-month price target of $2.3 implies -12.2% downside from current levels.
Is CRON stock overvalued or undervalued?
CRON trades at a forward P/E of 34.9333x, representing a moderate valuation. With analysts targeting $2.3 (-12.2% implied move), the stock appears close to fair value.
How high can CRON stock go?
The most bullish Wall Street analyst has a price target of $2.3 for CRON, while the most conservative target is $2.3. The consensus of $2.3 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover CRON stock?
CRON is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 9 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CRON stock forecast?
The 12-month CRON stock forecast based on 15 Wall Street analysts shows a consensus price target of $2.3, with estimates ranging from $2.3 (bear case) to $2.3 (bull case). The median consensus rating is "Hold".
What is CRON's forward P/E ratio?
CRON trades at a forward P/E ratio of 34.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CRON stock?
Analysts are cautious on CRON, with 3 Sell ratings and a price target of $2.3 (-12.2% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CRON price targets vary so much?
CRON analyst price targets range from $2.3 to $2.3, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2.3 consensus represents the middle ground.